The American Diabetes Association (ADA) has been criticized for ejecting five members from its scientific session in New Orleans, leading to significant backlash. Despite an apology and a review, members have protested through petitions and an 1,100-member boycott. The flagship journal has stopped accepting manuscripts and grant reviews, fundraisers, and educational activities have ceased. The ADA posted a news release about the review, which backs off from previous explanations, noting that the ADA’s code of conduct didn’t explicitly state that distributing materials inside the convention center was prohibited.
Key points
The American Diabetes Association (ADA) has faced backlash after ejecting five members fr…: The American Diabetes Association (ADA) has faced backlash after ejecting five members from its scientific session in New Orleans.
Despite an apology and a review, members have protested through petitions and an 1,100-me…: Despite an apology and a review, members have protested through petitions and an 1,100-member boycott.
The flagship journal has stopped accepting manuscripts and grant reviews, fundraisers, an…: The flagship journal has stopped accepting manuscripts and grant reviews, fundraisers, and educational activities have ceased.
Sources checked by our analysis pipeline: 1
Since five members of the American Diabetes Association were ejected from its scientific session in New Orleans on June 5, the professional organization has released two explanations, one apology, one summary of its review of the events, and one notice of further review. Members have protested through petitions and an 1,100-member boycott. The flagship journal has stopped accepting manuscripts and grant reviews, fundraisers, and educational activities have ceased.
On Friday, the ADA posted a news release about the long-awaited review, three days after it disclosed without explanation the departure of Rita Kalyani, its chief medical and scientific officer.
The post offers background for the evictions, citing a “written threat that there would be protest and disruption,” but also backs off from previous explanations, noting that the “ADA’s code of conduct didn’t explicitly state that distributing materials inside the convention center was prohibited.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Health Secretary Robert F. Kennedy Jr. is pushing for the first-ever federal definition of ultraprocessed foods (UPF), which account for more than 70% of the packaged food supply in the U.S. The Trump administration announced their efforts to define UPF in July 2025, but food company CEOs intervened, and Calley Means, MAHA's top ally, resigned citing a "breaking point" over the definition. This move could pave the way for informed decision-making on UPF, which are cheap, convenient, and readily available but linke…
A patient at Bristol Myers Squibb's early autoimmune CAR-T trial died following treatment, experiencing motor symptoms that did not improve despite standard treatments. The patient was given an immunosuppressant but developed septic pneumonia, leading to their death. This incident underscores safety concerns in CAR-T autoimmune trials and highlights the need for continued monitoring and improvement in treatment protocols.
A new analysis of cancer drugs approved by European regulators finds that most treatments lack high clinical benefits, with only 31% of 97 approved indications meeting the criteria. This highlights a "fundamental shift in the innovation ecosystem" and suggests that five drugmakers, primarily based in China and Japan, account for more than half of the top clinical benefit indications.